Serum Potassium Prediction Using Machine Learning and Single-lead ECG
Withdrawn before enrolling
Conditions studied: Infection, Heart Failure, Chronic Obstructive Pulmonary Disease, Asthma, Gout Flare, Chronic Kidney Diseases, Hypertensive Urgency, Atrial Fibrillation Rapid, Anticoagulants; Increased
In brief
This is a retrospective study drawing on data from the Brigham and Women's Hospital Home Hospital Program's Database. Sociodemographic and clinical data from a training cohort were used to train a machine learning algorithm to predict blood potassium throughout a patient's admission. This algorithm was then validated in a validation cohort.
Key facts
- Study ID
- NCT07493798
- Run by
- Brigham and Women's Hospital
- People needed
- 0
- Starts
- 2021-03-20
- Expected to finish
- 2021-12-01
- Last updated by the study team
- 2026-03-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Brigham and Women's Hospital — Boston, Massachusetts, United States
- Brigham and Women's Faulkner Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.